Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for POAF Prevention in VATS
NCT05753644Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in Atrial fibrillation (AFib) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Incidence of Postoperative Atrial Fibrillation at 48 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05753644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05753644.